FindTrial
Sign In

Evaluate the effect of Shigruadi Aschyotan (Eye drops) in the management of Kaphaja Abhishyanda w.s.r. to Seasonal Allergic Conjuctivitis.

A Clinical study to evaluate the effect of Shigruadi Aschyotan (Eye drops) in the management of Kaphaja Abhishyanda w.s.r. to Seasonal Allergic Conjuctivitis. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/081630
Enrollment
30
Registered
2025-03-04
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H108- Other conjunctivitis

Interventions

None listed

Sponsors

Rajiv Gandhi Govt post Graduate Ayurvedic College and Hospital,Paprola
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed suffering from Kaphaja Abhishyanda w.s.r Seasonal Allergic Conjunctivitis Patients willing to undergo trial,Patinets age group 10-70 years

Exclusion criteria

Exclusion criteria: Patients not willing to participate in study Patients suffering from blephritis, trichiasis, dacrocystitis ,corneal ulcer and trachoma Patients suffering from any systemic/ metabolic disorders i.e cardiovascular disease ,diabetes ,hypertension etc

Design outcomes

Primary

MeasureTime frame
Relief in sign and symptoms of Seasonal Allergic ConjunctivitisTimepoint: 7 days—

Secondary

MeasureTime frame
To compare the efficacy of shirgruadi Aschyotan with combination of (Phenylephrine, Naphazoline Hydrochloride, Menthol, Camphor) Eye dropsTimepoint: 7 days—

Countries

India

Contacts

Public ContactDr SukhDev Singh

R.G.G.P.G Ayurvedic College and Hospital

shiwaliv1441@gmail.com8988326521

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026